PMC9763271_01
The curve showing serum beta-hCG during the invasive mole development and in response to the treatment procedures.
fonc-12-1019082-g001.jpg
PMC9763271_01_fonc-12-1019082-g001.jpg
f1
Subsequently, she underwent a second suction and curettage, and the beta-hCG level further decreased to 5,718 mIU/ml ( Figure 1 ).
Pathological characteristic of the invasive mole. A representive image of HE staining demonstrating villi edema and trophoblast cells proliferation.
fonc-12-1019082-g002.jpg
PMC9763271_01_fonc-12-1019082-g002.jpg
f2
The results of the second pathological examination were consistent with those of the first ( Figure 2 ).
Transvaginal ultrasound. (A) Twenty-one days after the second molar evacuation. (B-D) The ultrasonographic image when the uterus perforation. The uterus was 9.4 x 9.7 x 6.9 cm, an uneven echo area of 10.7 x 7.1 x 5.7 cm was observed in uterine cavity and cervical canal, protruding left anterior wall, local muscle layer was unclear.
fonc-12-1019082-g003.jpg
PMC9763271_01_fonc-12-1019082-g003.jpg
f3
An ultrasonography examination showed that the uterus was 9.2 x 8.9 x 7.8 cm in size, an uneven echo area of 6.9 x 5.2 cm was near the fundus of the uterine cavity, the convex anterior wall had lost its normal muscle layer, and the outer margin was about 0.24 cm from the serosal layer ( Figure 3A ). An emergency abdominal ultrasound scan showed acute intra-abdominal bleeding (approximately 2,000 ml) ( Figures 3B-D ), and blood tests showed a hemoglobin concentration of 7.9 g/dL.
Pelvic MRI. Twenty-one days after the second molar evacuation, pelvic MRI scan showing a 7.1 x 6.1 x 8.2 cm mass invading the left anterior uterine wall, extending from the muscular layer to the serosal layer.
fonc-12-1019082-g004.jpg
PMC9763271_01_fonc-12-1019082-g004.jpg
f4
The lesion was about 7.1 x 6.1 x 8.2 cm, extending from the muscular layer to the serosal layer ( Figure 4 ).